Patent US4133891A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4133891A Expired / Lapsed US ⏱️ 0.0 years remaining

Peritoneal dialysis solution containing nitroprusside

Assignee: University of Missouri–St. Louis
•
Filing: 1977-03-28
•
Granted: 1979-01-09
•
Expires: 1997-03-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A peritoneal dialysis solution containing the vasodilating drug nitroprusside which is effective to increase peritoneal clearances and thereby permit a significant reduction in the time devoted to the performance of a dialysis procedure.

Inventors

  • 👤 Karl D. Nolph

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:48
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/28; A61K31/295

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 44 words
A peritoneal dialysis fluid containing the following ingredients in the approximate concentration of: 140 mEq/L sodium 101 mEq/L chloride 45 mEq/L acetate 1.5 mEq/L magnesium 4 mEq/L calcium; and the vasodilating drug nitroprusside in the approximate concentration of 3 to 6 mg. per liter.
Claim 2
Dependent Claim 44 words
A peritoneal dialysis fluid containing the following ingredients in the approximate concentration of: 140 mEq/L sodium 101 mEq/L chloride 45 mEq/L acetate 1.5 mEq/L magnesium 4 mEq/L calcium; and the vasodilating drug nitroprusside in the approximate concentration of 3 to 6 mg. per liter.
Claim 3
Independent Claim 84 words
A method for increasing peritoneal dialysis clearances within a patient surgically fitted with an indwelling catheter comprising the steps of: providing a dialysis fluid having in solution the ingredients in the concentrations as follows: 140 mEq/L sodium 101 mEq/L chloride 45 mEq/L acetate 1.5 mEq/L magnesium 4 mEq/L calcium; and adding the vasodilating drug nitroprusside in the approximate concentration of 3 to 6 mg. per liter to the dialysis fluid defined; and infusing said modified dialysis fluid into a patient through the indwelling catheter.
Claim 4
Independent Claim 84 words
A method for increasing peritoneal dialysis clearances within a patient surgically fitted with an indwelling catheter comprising the steps of: providing a dialysis fluid having in solution the ingredients in the concentrations as follows: 140 mEq/L sodium 101 mEq/L chloride 45 mEq/L acetate 1.5 mEq/L magnesium 4 mEq/L calcium; and adding the vasodilating drug nitroprusside in the approximate concentration of 3 to 6 mg. per liter to the dialysis fluid defined; and infusing said modified dialysis fluid into a patient through the indwelling catheter.
Claim 5
Dependent Claim 16 words
The peritoneal dialysis fluid of claim 1 including: 3 mEq/L potassium chloride as an additional ingredient.
Claim 6
Dependent Claim 20 words
The method of claim 2 including: adding potassium chloride in the approximate concentration of 3 mEq/L to the dialysis fluid.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-01-08 1982-07-10 1983-01-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-01-08 1986-07-10 1987-01-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-01-08 1990-07-10 1991-01-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag